Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 8,699Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Actavis Inc

02 2Link Healthcare

03 3Pharma Swiss Ceska republika sro

04 2Pharma Swiss Ceská Republika s.r.o

05 5Salix Pharmaceuticals

06 1TMC PHARMA SERVICE LTD

07 1US GENERICS, STERILES

08 1Viatris

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

METHYLNALTREXONE BROMIDE

Brand Name : METHYLNALTREXONE BROMIDE

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 8MG/0.4ML (8MG/0.4ML)

Packaging :

Approval Date : 2024-08-26

Application Number : 208112

Regulatory Info : RX

Registration Country : USA

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

METHYLNALTREXONE BROMIDE

Brand Name : METHYLNALTREXONE BROMIDE

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 12MG/0.6ML (12MG/0.6ML)

Packaging :

Approval Date : 2024-08-26

Application Number : 208112

Regulatory Info : RX

Registration Country : USA

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

methylnaltrexone

Brand Name : Relistor

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

methylnaltrexone

Brand Name : Relistor

Dosage Form :

Dosage Strength :

Packaging : 7

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

METHYLNALTREXONE BROMIDE

Brand Name : RELISTOR

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 12MG/0.6ML (12MG/0.6ML)

Packaging :

Approval Date : 2008-04-24

Application Number : 21964

Regulatory Info : RX

Registration Country : USA

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

METHYLNALTREXONE BROMIDE

Brand Name : RELISTOR

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 8MG/0.4ML (8MG/0.4ML)

Packaging :

Approval Date : 2010-09-27

Application Number : 21964

Regulatory Info : RX

Registration Country : USA

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

METHYLNALTREXONE BROMIDE

Brand Name : RELISTOR

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 12MG/0.6ML (12MG/0.6ML)

Packaging :

Approval Date : 2010-09-27

Application Number : 21964

Regulatory Info : RX

Registration Country : USA

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

METHYLNALTREXONE BROMIDE

Brand Name : RELISTOR

Dosage Form : TABLET;ORAL

Dosage Strength : 150MG

Packaging :

Approval Date : 2016-07-19

Application Number : 208271

Regulatory Info : RX

Registration Country : USA

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

METHYLNALTREXONE BROMIDE

Brand Name : RELISTOR

Dosage Form : SOLUTION

Dosage Strength : 20MG/ML

Packaging : 0.6ML

Approval Date :

Application Number : 2308215

Regulatory Info : Prescription

Registration Country : Canada

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

METHYLNALTREXONE BROMIDE

Brand Name : METHYLNALTREXONE BROMIDE

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 12MG/0.6ML

Packaging :

Approval Date :

Application Number : 208592

Regulatory Info :

Registration Country : USA

blank

11

US GENERICS, STERILES

Country
2024 ACI Convention
Not Confirmed
arrow

US GENERICS, STERILES

Country
arrow
2024 ACI Convention
Not Confirmed

METHYLNALTREXONE BROMIDE

Brand Name : METHYLNALTREXONE BROMIDE

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 12MG/0.6ML

Packaging :

Approval Date :

Application Number : 208038

Regulatory Info :

Registration Country : USA

blank

12

Pharma Swiss Ceska republika sro

Country
2024 ACI Convention
Not Confirmed
arrow

Pharma Swiss Ceska republika sro

Country
arrow
2024 ACI Convention
Not Confirmed

methylnaltrexone bromide

Brand Name : Relistor

Dosage Form : SOLUTION FOR INJECTION

Dosage Strength : 12 MG / 0.6 ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

13

Pharma Swiss Ceska republika sro

Country
2024 ACI Convention
Not Confirmed
arrow

Pharma Swiss Ceska republika sro

Country
arrow
2024 ACI Convention
Not Confirmed

methylnaltrexone bromide

Brand Name : Relistor

Dosage Form : SOLUTION FOR INJECTION, PRE-FILLED SYRINGE

Dosage Strength : 12 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

14

Pharma Swiss Ceska republika sro

Country
2024 ACI Convention
Not Confirmed
arrow

Pharma Swiss Ceska republika sro

Country
arrow
2024 ACI Convention
Not Confirmed

methylnaltrexone bromide

Brand Name : Relistor

Dosage Form : SOLUTION FOR INJECTION, PRE-FILLED SYRINGE

Dosage Strength : 8 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

15

TMC PHARMA SERVICE LTD

Country
2024 ACI Convention
Not Confirmed
arrow

TMC PHARMA SERVICE LTD

Country
arrow
2024 ACI Convention
Not Confirmed

Relistor

Brand Name : Relistor

Dosage Form : Metilnaltrexone 12Mg 7 Joined The Parenteral Use

Dosage Strength : 7 VIALS SC 12 mg 0.6 ml + 7 Syringes

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

16

Pharma Swiss Ceská Republika s.r.o

Country
2024 ACI Convention
Not Confirmed
arrow

Pharma Swiss Ceská Republika s.r.o

Country
arrow
2024 ACI Convention
Not Confirmed

Relistor

Brand Name : Relistor

Dosage Form : Injection fluid, resolution

Dosage Strength : 12 mg/0.6 ml

Packaging : Hood glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

17

Pharma Swiss Ceská Republika s.r.o

Country
2024 ACI Convention
Not Confirmed
arrow

Pharma Swiss Ceská Republika s.r.o

Country
arrow
2024 ACI Convention
Not Confirmed

Relistor

Brand Name : Relistor

Dosage Form : Injection fluid, resolution

Dosage Strength : 12 mg/0.6 ml

Packaging : Hood glass

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank